Substantial reaction between histamine and malondialdehyde: A new observation of carbonyl stress

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 799-805

  Li, Li ^a   Li, Goulin ^a   Sheng, Shuli ^b   Yin, Dazhong ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Carbonyl stress; Ceroid lipofuscin like pigment; De carbonylation; Histamine; Malondialdehyde; Oxidative glycation stresses

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; CARBONYL DERIVATIVE; CEROID; ENAMINE; HISTAMINE; LIPOFUSCIN; MALONALDEHYDE;

ARTICLE; BRAIN TOXICITY; CARBONYLATION; CHEMICAL REACTION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NERVE CELL DEGENERATION; PATHOPHYSIOLOGY; PH; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY;

EID: 33645015944     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11(1):81-128.
2. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003; 9(4):169-76.
3. Janero DR. Malondialclehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Bio Med. 1990; 9(6):515-40.
4. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicol 2003; 189(1-2):41-5.
5. Kikugawa K, Machida Y, Kida M, Kurechi T. Study on peroxidized lipids III Fluorescent pigments derived from the reaction of malonaldehyde and amino acids. Chem Pharm Bull. 1981; 29(10):3003-11.
6. Yin DZ. Biochemical basis of lipofuscin, ceriod, and age pigment like fluorophores. Free Radical Bio Med 1996; 21(6):871-88.
7. Picklo MJ, Montine TJ, Amarnath V, Neely MD. Carbonyl toxicology and Alzheimer's disease. Toxicol Appl Pharmacol 2002; 184(3):187-97.
8. Pocernich CB, Cardin AL, Racine CL, Lauderback CM, Butterfield DA. Glutathione elevation and its protective role in acrolein-incluced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem Int 2001; 39(2):141-9.
9. Leurs R, Smit MJ, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995; 66(3):413-63.
10. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63(6):637-72.
11. Siegel JM. The neurotransmitters of sleep. J Clin Psychiatry 2004; 65(suppl 16):4-7.
12. Garbarg M, Barbin G, Feger J, Schwartz J-C. Histaminergic pathway in rat brain evidenced by lesions of the medial forebrain bundle. Science. 1974; 186(4166):833-5.
13. Schneider C, Risser D, Kirchner L, Kitzmuller E, Cairns N, Parst Helmut, Singewald N, Lubec G. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Neurosci Lett 1997; 222(3):183-6.
14. Fernandez-Novoa L, Cacabelos R. Histamine function on brain disorders. Behav Brain Res 2001; 124(2):213-33.
15. Kim SH, Cairns N, Fountoulakisc M, Lubec G. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci Lett 2001; 300(1):41-4.
16. Masini E, Palmerani B, Gambassi F, Pistelli A, Giannella E, Occupati B, Ciuffi M, Sacchi TB, Mannaioni PF. Histamine release from rat mast cells induced by metabolic activation of polyunsaturated fatty acids into free radicals. Biochem Pharmacol 1990; 39(5):879-89.
17. Schneider E, Rolli-Derkinderen M, Arock M, Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 2002; 23(5):255-63.
18. Ito C. The role of brain histamine in acute and chronic stresses. Biomed Pharmacother 2000; 54(5):263-7.
19. d'Ischia M, Costantini C, Prota G. Lipofuscin-like pigments by autoxidation of polyunsaturated fatty acids in the presence of amine neurotransmitters: the role of malondialdehyde. Biochem Biophys Acta. 1996; 1290(3):319-26.
20. d'Ischia M, Costantini C, Prota G. Reaction of malondialdehyde with amine neurotransmitters. Formation and oxidation chemistry of fluorescent 1, 4-dihydropyridine adducts. Tetrahedron 1995; 51 (34):9501-8.
21. Li G, Li L, Yin D. A novel observation: melatonin's interaction with malondialdehyde. Neuro Endocrinol Lett 2005; 26(1):61-6.
22. Glantz SA. Primer of Biostatistics. New York: McGraw-Hill Press; 1981.p.352.
23. Nair V, Cooper CS, Vietti DE, Turner GA. The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids 1986; 21(1):6-10.
24. Xu D, Thiele GM, Kearly ML, Haugen MD, Klassen LW, Sorrell MF, Tuma DJ. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme linked immunosorbent assay. Chem Res Toxicol 1997; 10(9):978-86.
25. Tuma D, Thiele G, Xu D, Klassen L, Sorrell M. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatol 1996; 23(4):872-80.
26. Yin D. Is carbonyl detoxification an important anti-aging process during sleep? Med Hypotheses. 2000; 54(4):519-22.
27. Yin D, Chen K. The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol 2005; 40(6):455-65.